Actinic keratosis or AK is a rough, scaly patch of skin that develops due to years of sun exposure. A small percentage of actinic keratosis spots can actually turn into skin cancer, Common places for actinic keratosis to develop include face, lips, ears, scalp, neck, backs of hands, and forearms.
This report contains market size and forecasts of Actinic Keratosis Drugs in global, including the following market information:
- Global Actinic Keratosis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Actinic Keratosis Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Actinic Keratosis Drugs companies in 2021 (%)
The global Actinic Keratosis Drugs market was valued at 4318.7 million in 2021 and is projected to reach US$ 5438.9 million by 2028, at a CAGR of 3.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Topical Treatment Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Actinic Keratosis Drugs include Almirall, GALDERMA, LEO Pharma, Valeant, Biofrontera, Novartis, Perrigo, Promius Pharma and Taro Pharmaceutical Industries, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Actinic Keratosis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Actinic Keratosis Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Actinic Keratosis Drugs Market Segment Percentages, by Type, 2021 (%)
- Topical Treatment Drugs
- Photodynamic Therapy Drugs
- Combination Therapy Drugs
Global Actinic Keratosis Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Actinic Keratosis Drugs Market Segment Percentages, by Application, 2021 (%)
Global Actinic Keratosis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Actinic Keratosis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Actinic Keratosis Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Actinic Keratosis Drugs revenues share in global market, 2021 (%)
- Key companies Actinic Keratosis Drugs sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Actinic Keratosis Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Almirall
- GALDERMA
- LEO Pharma
- Valeant
- Biofrontera
- Novartis
- Perrigo
- Promius Pharma
- Taro Pharmaceutical Industries
- TOLMAR Pharmaceuticals
- Vidac Pharma
